Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML.
Damaskou A, Wilson R, Gozdecka M, Giotopoulos G, Asby R, Eleftheriou M, Gu M, Récher C, Mansat-De Mas V, Vergez F, Sahal A, Vick B, Papachristou EK, Sawle A, Yankova E, Dudek M, Liu X, Russell J, Rak J, Hilcenko C, D'Santos CS, Jeremias I, Sarry JE, Tzelepis K, Huntly BJ, Warren AJ, Tavana O, Vassiliou GS.
Damaskou A, et al. Among authors: gu m.
Blood. 2025 Jun 25:blood.2024026113. doi: 10.1182/blood.2024026113. Online ahead of print.
Blood. 2025.
PMID: 40561247